EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Adalimumab Reprograms M1 Macrophages to Attenuate Th1/Th17 Responses in Behçet's Uveitis and Vogt–Koyanagi–Harada Syndrome

Yunyun Zhu, Qiuyue Yu, Yangyang Ma, Li Huang, Jianguang Ding, Xiuhua Gao, Lili Ma, Dike Zhang, Bin Zhang, Sen Wang, Wai Kit Chu, Guannan Su und 1 weitere

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.6.4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Yunyun Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China. Hauptthemen laut MEDLINE: Uveomeningoencephalitic Syndrome, Adalimumab, Macrophages, Th1 Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uveomeningoencephalitic SyndromeAdalimumabMacrophagesTh1 CellsTh17 CellsBehcet SyndromeAnti-Inflammatory AgentsUveitisHumansAnimalsEnzyme-Linked Immunosorbent AssayFlow CytometryFemaleMaleCytokinesBlotting, WesternReal-Time Polymerase Chain ReactionCells, CulturedDisease Models, AnimalCD4-Positive T-LymphocytesAdult

Substanzen

AdalimumabCytokinesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Ophthalmology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China.
  • Postdoctoral Mobile Station of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
  • Department of Ophthalmology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
  • Department of Emergency, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China.
  • Department of Laboratory Medicine, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China.
  • Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

Zitieren

APA

Zhu, Y., Yu, Q., Ma, Y., Huang, L., Ding, J., Gao, X., Ma, L., Zhang, D., Zhang, B., Wang, S., Chu, W. K., Su, G., & Yang, P. (2026). Adalimumab Reprograms M1 Macrophages to Attenuate Th1/Th17 Responses in Behçet's Uveitis and Vogt–Koyanagi–Harada Syndrome. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.6.4

Vancouver

Zhu Y, Yu Q, Ma Y, Huang L, Ding J, Gao X, et al. Adalimumab Reprograms M1 Macrophages to Attenuate Th1/Th17 Responses in Behçet's Uveitis and Vogt–Koyanagi–Harada Syndrome. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.6.4

BibTeX
@article{Zhu2026,
  author = {Zhu, Yunyun and Yu, Qiuyue and Ma, Yangyang and Huang, Li and Ding, Jianguang and Gao, Xiuhua and Ma, Lili and Zhang, Dike and Zhang, Bin and Wang, Sen and Chu, Wai Kit and Su, Guannan and Yang, Peizeng},
  title = {Adalimumab Reprograms M1 Macrophages to Attenuate Th1/Th17 Responses in Behçet's Uveitis and Vogt–Koyanagi–Harada Syndrome},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.6.4}
}
Kostenlos starten →